• Atiya Rahman
  • Syed Dilawar Abbas Rizvi
  • Zafar Iqbal Sheikh


Background: Hepatitis C Virus (HCV) has estimated affected nearly 3% of the world population.Studies in Pakistan have shown a somewhat higher prevalence. The objective of this study was todetermine the frequency of hepatitis C virus infection in patients with dermatological disorders, knownto be associated with HCV infection. Method: This was a descriptive study, conducted at Departmentsof Dermatology, Military Hospital, Rawalpindi and PNS Shifa, Karachi from September 2003 toNovember 2005. There were 355 patients of the dermatologic disorders mentioned above. HCV statuswas determined by the presence of anti-HCV antibodies in the serum, by third generation ELISA.Results: In this study 14% of lichen planus, 8% of generalised pruritus, 7.8% of urticaria, 8.7% ofprurigo, and 50% of porphyria cutanea tarda patients had underlying HCV infection. None of thepatients of leukocytoclastic vasculitis, erythema multiforme or erythema nodosum had anti-HCVantibodies. No patient of mixed cryoglobulinaemia or polyarteritis nodosa was seen during the studyperiod. Conclusions: Patients of lichen planus, generalised pruritus, urticaria, prurigo, and porphyriacutanea tarda have increased frequency of HCV infection compared to normal population of ourcountry. In contrast, none of the patients of leukocytoclastic vasculitis, erythema multiforme orerythema nodosum had HCV infection.Keywords: HCV, cutaneous disorders, lichen planus, porphyria cutanea tarda, urticaria, pruritus,prurigo, erythema multiforme, erythema nodosum


Higuchi M, Tanaka E, Kiyosawa K. Epidemiology and clinical

aspects on hepatitis C. Jpn J Infect Dis 2002;55:69–77.

Muhammad N, Jan A. Frequency of Hepatitis C in Buner, NWFP.

J Coll Physicians Surg Pak 2005;15:11–4.

Khokhar N, Gill ML, Malik GJ. General sero-prevalence of

Hepatitis C and Hepatitis B virus infection in population. J Coll

Physicians Surg Pak 2004;14:534–6.

Rebora A. Skin diseases associated with hepatitis C virus: facts

and controversies. Clin Dermatol 2010;28:489–96.

Mahboob A, Haroon TS, Iqbal Z, Iqbal F, Butt AK. Frequency of

anti-HCV antibodies in patients with lichen planus. J Coll

Physicians Surg Pak 2003;13:248–51.

Daramola OO, George AO, Ogunbiyi AO. Hepatitis C virus and

lichen planus in Nigerians: any relationship? Inter J Dermatol


Gimenez-Garcia R, Perez-Castrillon JL. Lichen planus and

hepatitis C virus infection. J Eur Acad Dermatol Venereol


Mignogna MD, Lo Muzio L, Favia G, Mignogna RE, Carbone R,

Bucci E. Oral lichen planus and HCV infection: a clinical

evaluation of 263 cases. Int J Dermatol 1998;37:575–8.

Kurokawa M, Hidaka T, Sasaki H, Nishikata I, Morishita K,

Setoyama M. Analysis of hepatitis C virus (HCV) RNA in the

lesions of lichen planus in patients with chronic hepatitis C:

detection of anti-genomic as well as genomic-strand HCV RNAs

in lichen planus lesions. J Dermatol Sci 2003;32:65–70.

Arrieta JJ, Rodriquez-Iniqo E, Casqueiro M, Bartolom J,

Manzarbeitia F, Herrero M, et al. Detection of hepatitis C virus

replication by In situ hybridization in epithelial cells of antihepatitis C virus-positive patients with and without oral lichen

planus. Hepatology 2000;32:97–103.

Maticic M, Poljak M, Lunder T, Rener-Sitar K, Stojanovic L.

Lichen planus and other cutaneous manifestations in chronic

hepatitis C: pre- and post-interferon-based treatment prevalence

vary in a cohort of patients from low hepatitis C virus endemic

area. J Eur Acad Dermatol Venereol. 2008;22(7):779–88.

Zirwas MJ, Seraly MP. Pruritus of unknown origin: a

retrospective study. J Am Acad Dermatol 2001;45:892–6.

Raychaudhuri SP, Kaplan M. Chronic urticaria and hepatitis C. Int

J Dermatol 1995;34:823–4.

Kanazawa K, Yaoita H, Tsuda F, Okamoto H. Hepatitis C virus

infection in patients with urticaria. J Am Acad Dermatol


Tousi P, Rahmati M, Khorshid SM. Urticaria and HCV infection:

is there a relationship? Int J Dermatol 2002;41:712–5.

Jalil S, Grady JJ, Lee C, Anderson KE. Associations among

behavior-related susceptibility factors in porphyria cutanea tarda.

Clin Gastroenterol Hepatol 2010;8(3):297–302.

Gisbert JP, Garcia-Buey L, Pajares JM, Moreno-Otero R.

Prevalence of hepatitis C virus infection in porphyria cutanea

tarda: systematic review and meta-analysis. J Hepatol


Podányi B, Kiss A, Kaposi-Novák P, Lengyel G, Horányi M,

Schaff ZS, Horváth A. Hepatitis C virus RNA in the cutaneous

eruption but not in the symptom-free skin from patient with

prurigo simplex and chronic C hepatitis. J Eur Acad Dermatol

Venereol 2005;19:520–2.

Kanazawa K, Yaoita H, Tsuda F, Murata K, Okamoto H.

Association of prurigo with hepatitis C virus infection. Arch

Dermatol 1995;131:852–3.

El-Darouti MA, Mashaly HM, El-Nabarawy E, Eissa AM, AbdelHalim MR, Fawzi MM, et al. Leukocytoclastic vasculitis and

necrolytic acral erythema in patients with hepatitis C infection: do

viral load and viral genotype play a role? J Am Acad Dermatol


Rahman SB, Sheikh ZI, Hameed A, Khan AA. Leucocytoclastic

vasculitis. Pak Armed Forces Med J 1995;45:51–4.

Calista D, Landi G. Lichen planus, erythema nodosum, and

erythema multiforme in a patient with chronic hepatitis C. Cutis


Geraminejad P, Walling HW, Voigt MD, Stone MS. Severe

erythema multiforme responding to interferon alfa. J Am Acad

Dermatol 2006;54(2 Suppl):S18–21.

Mert A, Ozaras R, Tabak F, Pekmezci S, Demirkesen C, Ozturk

R. Erythema nodosum: an experience of 10 years. Scand J Infect

Dis 2004;36:424–7.